- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inogen Inc (INGN)
The Inogen Inc share price today is 6.54, view NASDAQ INGN stock exchange data. Track the latest Inogen Inc share price with real-time updates on INGN stock performance including market cap, day range, 52-week range and dividend yield. Access INGN charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.51
6.78
52 wk Range
5.34
9.13
INGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.516.78
52 wk Range
5.349.13
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
12.67
Upside
+93.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
- Inogen names Andy Reding as chief operating officer
- Investing.com
- Inogen names Andy Reding as chief operating officer
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.67
(+93.68% Upside)
Inogen Inc Earnings Call Summary for Q1/2026
- Inogen Q1 2026 revenue hit $85.1M, beating forecast by 3.34%, but EPS of -$0.3 missed estimates, triggering 1.27% stock decline after-hours
- International sales surged 18% YoY, offsetting U.S. market weakness; adjusted gross margin improved to 44.7%, up 30 basis points year-over-year
- Company posted net loss of $8.3M GAAP ($4.0M adjusted) as operating expenses rose 5.1% to $43.0M due to increased R&D investment
- Management projects continued losses with Q3 2026 EPS at -$0.18 and Q4 at -$0.16, though revenue expected to reach $97.25M in Q3
- CEO Smith cited new Aurora CPAP mask launch and international expansion as growth drivers despite domestic market pressures and profitability challenges
Last Updated: 12-05-2026, 12:52 am
Read Full TranscriptEarnings
Latest Release
07-05-2026
EPS / Forecast
-0.30 / -0.29
Revenue / Forecast
85.1M / 82.35M
Compare INGN to Peers and Sector
Metrics to compare | INGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.1x | −17.0x | −0.4x | |
PEG Ratio | −0.36 | −0.11 | 0.00 | |
Price/Book | 1.0x | 8.1x | 2.6x | |
Price / LTM Sales | 0.5x | 4.9x | 3.1x | |
Upside (Analyst Target) | 79.9% | 62.1% | 48.3% | |
Fair Value Upside | Unlock | −5.0% | 6.1% | Unlock |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Inogen Inc (INGN) Share Price Today?
The Inogen Inc share price today is 6.54.
What is the current Inogen Inc (INGN) share price and day range?
As of 07-07-2026, the Inogen Inc share price is 6.54, with a previous close of 6.67. The share price has ranged from 6.51 to 6.78 today, while the 52-week range spans from 5.34 to 9.13.
What Is the Inogen Inc Market Cap?
As of today, Inogen Inc market cap is 177.88M.
What Is the Inogen Inc (INGN) Share Price Target?
The average 12-month share price target for Inogen Inc is 12.67, with a high estimate of 14 and a low estimate of 12. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +93.68% Upside potential.
What Is Inogen Inc's Earnings Per Share (TTM)?
The Inogen Inc EPS (TTM) is -0.92.
When Is the Next Inogen Inc Earnings Date?
Inogen Inc will release its next earnings report on 12-08-2026.
From a Technical Analysis Perspective, Is INGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Inogen Inc Trade On?
Inogen Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Inogen Inc?
The stock symbol for Inogen Inc is "INGN."
How Many Times Has Inogen Inc Stock Split?
Inogen Inc has split 0 times.
How Many Employees Does Inogen Inc Have?
Inogen Inc has 753 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.